Drawing for GASTRIC-BAND-EFFECT

USPTO serial 86973920

GASTRIC-BAND-EFFECT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KEAM, ALEX S
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GASTRIC-BAND-EFFECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stewart J. Bellus

STEWART J. BELLUS COLLARD AND ROE=1077 NORTHERN BLVDROSLYN, NY 11576-1614UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003essential oils; cosmeticsACTIVE—
005Dietary supplements and dietetic preparations; Flaxseed dietary supplements; Albumin dietary supplements; Propolis dietary supplements; Enzyme dietary supplements; Casein dietary supplements; Protein dietary supplements; Yeast dietary supplements; Pollen dietary supplements; Glucose dietary supplements; Lecithin dietary supplements; Dietary food supplements; Alginate dietary supplements; Dietary supplements for infants; Dietary supplement drink mixes; Dietary and nutritional supplements; Dietary supplements for humans; Flaxseed oil dietary supplements; Dietary supplements for animals; Soy protein dietary supplements; Wheat germ dietary supplements; Royal jelly dietary supplements; Dietetic substances for babies, namely, food in the nature of vitamins and nutritional supplements sold in the form of pills, capsules, tablets, powders, and liquids; Starch for dietetic use, namely, in the nature of nutritional supplements sold in the form of pills, capsules, tablets, powders, and liquids; Diet pills; Diet capsules; Dietary supplements; Dietary supplemental drinks; Wheat dietary supplements; Mineral dietary supplements for humans; Dietary supplements for medical use; Dietary supplements for human consumption; Dietary supplements consisting of vitamins; Dietary supplements for controlling cholesterol; Mineral dietary supplements for animals; Food supplements for dietetic use; Dietetic sugar substitutes for medical use; Dietetic beverages adapted for medical purposes, namely, nutritionally fortified beverages for medical purposes; Dietetic preparations adapted for medical use, namely, food in the nature of vitamins and nutritional supplements sold in the form of pills, capsules, tablets, powders, and liquids; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Vitamins and dietary food supplements for animals; Dietary and nutritional supplements for endurance sports; Lecithin for use as a dietary supplement; Powdered fruit-flavored dietary supplement drink mix; Dietary and nutritional supplements used for weight loss; Dietetic beverages for babies adapted for medical purposes, namely, nutritionally fortified beverages for babies for medical purposes; Dieting pills and powder preparations to promote fat burning; Dietary supplements in the nature of weight loss powders; Nutritional and dietary supplements formed and packaged as bars; Ground flaxseed fiber for use as a dietary supplement; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements for pets in the nature of a powdered drink mix; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary supplements for humans and/or animals; Dietary supplements and vitamins and minerals for the treatment of diseases or ailments, namely, immune system disorders, nervous system disorders, metabolic disorders, cancer, diabetes, sleeping disorders, rheumatic disorders, allergies, attention deficit syndrome and veterinary preparations for pain relief medication; Dietary supplements also containing flaxseed and/or wheat and/or turmeric; Dietary supplements also consisting of iron and/or zinc and/or calcium; Sanitary preparations for medical purposes; Dietetic substances, namely, foods in the nature of vitamins and nutritional supplements sold in the form of pills, capsules, powders, and liquids adapted for medical use; disinfectants, namely, all-purpose disinfectants; disinfectant bathroom cleaners; preparations for destroying vermin; fungicides and herbicidesACTIVE—
009Downloadable electronic books in the field of dietary advice and/or use of dietary supplements and/or description of a diet-effect by psychological nature; E-books in the field of dietary advice and/or use of dietary supplements and/or description of a diet-effect by psychological nature; Audio-books in the field of dietary advice and/or use of dietary supplements and/or description of a diet-effect by psychological nature; CDs, DVDs, and electronic storage devices, namely, downloadable audio files, downloadable video files, USB flash drives, smart media in the nature of blank electronic storage media, computer disc micro drives, external computer hard drives, and pre-recorded electronic storage media, all featuring dietary advise and/or information about use of dietary supplements and/or description of a diet-effect by psychological natureACTIVE—
016Books in the field of dietary advice and/or use of dietary supplements and/or description of a diet-effect by psychological natureACTIVE—
044Dietetic advisory services; Counselling relating to diet; Dietary and nutritional guidance; Provision of dietetic advice; Nutrition and dietetic consultancy; Professional consultancy relating to diet; Advisory services relating to dietACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 23, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 23, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 20, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 18, 2017EX1GSOU EXTENSION 1 GRANTED—
Oct 18, 2017EXT1SOU EXTENSION 1 FILED—
Oct 18, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 20, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 25, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 25, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 17, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 9, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 9, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Mar 9, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 9, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 9, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 7, 2017ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 28, 2017PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Feb 13, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 10, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 3, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Feb 3, 2017ALIEASSIGNED TO LIE—
Feb 3, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 3, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 3, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 26, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 26, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 26, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2016GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 2, 2016GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 2, 2016CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 28, 2016DOCKASSIGNED TO EXAMINER—
Apr 18, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 16, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance